$CROX

Crocs Shares Rise 19% as Q3 Revenue Reaches $1.04 Billion and 2026 Guidance Increases

Crocs (CROX) reported Q3 2026 revenue of $1.04B, up 4.6% YoY, and raised full-year guidance. Adjusted EPS was $3.69, beating estimates. Both Crocs and HEYDUDE brands grew, with international sales driving performance. Shares rose 19.41% premarket.

Original reporting
Published Oct 29, 2026, 3:05 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 29, 2026, 4:06 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Crocs Shares Rise 19% as Q3 Revenue Reaches $1.04 Billion and 2026 Guidance Increases — source image
Decision brief

The 30-second read

$CROXBullishHigh
01

Why it matters

The earnings beat and guidance raise expectations for continued revenue growth, likely attracting momentum traders.

02

Market read

Earnings beat and guidance lift make CROX a near‑term buying opportunity.

03

What to watch

Potential supply chain constraints or slower international growth could temper future performance.

Relevance 9/10Novelty 9/10Timing: pre‑market today

Background

Crocs (NASDAQ:CROX) is a global footwear brand known for its casual shoes and the HEYDUDE line.

Company-level read

Ticker impact

$CROXBullishHigh confidence
Context

Crocs reported Q3 earnings and revenue above expectations, raised full-year guidance and shares jumped 19% pre‑market.

Expected impact

upward pressure as investors price in higher earnings and guidance

Evidence & confidence

Earnings beat, margin expansion, and a sizable share repurchase signal improved fundamentals, supporting a near‑term price rise.

Market effects

Footwear and apparel sector may see a lift as Crocs' performance highlights consumer demand resilience.

U.S. consumer discretionary stocks could benefit from the upbeat earnings trend.

Limited to U.S. markets; no direct global macro impact.

Counterpoint

If the guidance upgrade is already priced in, the stock could face a short‑term pullback after the initial rally.

Key entities

  • Andrew Rees

    CEO of Crocs who commented on the strong quarter.

Related articles

$CROXMed

UBS raises Crocs stock price target to $145 on strong results

UBS raised its price target on Crocs (CROX) to $145 from $120, citing strong Q3 results and raised guidance. The stock has surged 26% in a week. UBS noted macro uncertainty but sees balanced risk. Crocs reported adjusted earnings of $3.69 per share and revenue of $1.04B, exceeding expectations. Goldman Sachs also raised its target to $128 but maintained a Sell rating.

$CROXMed

Goldman Sachs raises Crocs stock price target on growth outlook

Goldman Sachs raised its price target on Crocs (CROX) to $128 from $95, citing stronger growth, improved profitability, and a positive outlook. The stock has surged 75.7% year-to-date. Crocs reported stronger-than-expected Q3 results, with adjusted earnings of $3.69 per share and revenue of $1.04 billion, raising its full-year outlook. The HEYDUDE brand showed positive performance after two years of negative results.

$CROXHighAI 9/10

"I thought ugly shoes were a thing of the past"... Crocs shares stage stunning turnaround after plunging 30%

Crocs shares surged 25.54% to $150.26 after strong Q3 results and an upgraded full-year outlook. Adjusted EPS of $3.69 beat estimates, and revenue reached $1.04 billion. HEYDUDE, a subsidiary, saw a 6.1% revenue increase. CEO Andrew Rees cited growth across brands and regions. Last year, shares plunged 30% due to weak guidance and market trends.